Skip to main content
. 2022 Dec 30;145(2):1136–1143. doi: 10.1021/jacs.2c10819

Figure 4.

Figure 4

(A) Labeling of MRSA USA300 transposon mutants with 4. All mutants shown except FphE. (B) Wild type (WT) MRSA USA300 treated with probe 4. Bands annotated with corresponding proteins. (C) Labeling of the FphE transposon mutant.